| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |